Reckitt Benckiser Aktie News

Eine Jury in St. Louis wies am Donnerstag die Behauptungen zurück, dass die spezialisierte Formel für Frühgeborene von Reckitt‑Tochter Mead Johnson die gefährliche Darmerkrankung eines Säuglings verursacht habe.

Reckitt Benckiser is experiencing a market overreaction to the downside, creating an attractive entry point below £46/share. RBGLY's recent share price decline is driven by temporary macro headwinds—oil price sensitivity and a weak cold/flu season—not by fundamental business weakness. I have rebased my valuation to a 15x P/E multiple, lowering my price target to £46/share, and now rate the stoc...

Reckitt Benckiser's 30% Collapse Makes The Stock A "Buy" Again (Rating Upgrade)